Search

everythinglearnresearchcommunity

for

Search:↓

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with PCOS often have liver disease, so liver health checks are important for them.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

PCOS symptoms vary by age, affecting diagnosis and treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.